InsiderTrades

Form 4 for DOC Healthpeak Properties

Accepted 2025-02-03 00:00:00 ET · period of report 2025-01-30 · accession 0001628280-25-003496 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
2025-02-03 2025-01-31 DOC Alonso Lisa A EVP, Chief HR Off F - Tax $20.51 -1,480 21.6K -6% -$30.4K
M 2025-02-03 2025-01-30 DOC Alonso Lisa A EVP, Chief HR Off A - Grant $0.00 +6,948 23.1K +43% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2025-01-31 F D 1,480 $20.51 21,594 D — — (F4) This forfeiture of shares to satisfy applicable tax withholding does not constitute a sale transaction. Pursuant to the award agreement, shares are required to be forfeited to satisfy applicable tax withholding in connection with the vesting of restricted stock units granted on February 10, 2022.
2 Common Common Stock 2025-01-30 A A 4,431 $0.00 20,557 D — — (F1) Represents performance-based restricted stock units previously granted to the reporting person by the Issuer on February 16, 2024. The performance condition applicable to the award was determined to have been satisfied by the Issuer's Compensation and Human Capital Committee (the "Committee") on January 30, 2025 (the "Determination Date"), resulting in one-third (1/3) of the shares subject to the award vesting on each of the first, second and third anniversaries of the grant date, subject to the reporting person's continued employment with the Issuer through the applicable vesting date. (F2) Each restricted stock unit represents the right to receive one share of common stock, subject to the applicable vesting schedule.
3 Common Common Stock 2025-01-30 A A 2,517 $0.00 23,074 D — — (F3) Represents the number of performance-based restricted stock units previously granted to the reporting person by the Issuer on February 10, 2022. The performance conditions applicable to the award were determined to have been satisfied by the Issuer's Committee on the Determination Date, resulting in the award vesting in full on the Determination Date.